Fixation for the Treatment of Femoral Neck Fractures

June 11, 2018 updated by: Hebei Medical University Third Hospital

the Fixation Method for the Treatment of Femoral Neck Fractures

The femoral neck fracture is the most prevalent injuries which commonly encountered among older people with high mortality, morbidity and young fit healthy ones who subjected to high-energy trauma . Non-union or avascular necrosis of femoral neck fracture which lead to loss of labor capacity and death, is the most commonly occurred complication and results in considerable burden for family. The treatment is difficult and challenging, and to minimize the negative results such as limited mobilization or other complications, it is essential to take active prevention and appropriate treatment depending on fracture pattern and patients' characteristics as early as possible. However, current implant selections for femoral neck fractures remain a topic of greater interest and controversy, and vary substantially from each other .

Study Overview

Status

Unknown

Intervention / Treatment

Detailed Description

The incidence of femoral neck fracture accounts for 3.6% of all fractures, is the most prevalent injuries which commonly encountered among older people with high mortality, morbidity and young fit healthy ones who subjected to high-energy trauma . Non-union or avascular necrosis of femoral neck fracture which lead to loss of labor capacity and death, is the most commonly occurred complication and results in considerable burden for family. The treatment is difficult and challenging, and to minimize the negative results such as limited mobilization or other complications, it is essential to take active prevention and appropriate treatment depending on fracture pattern and patients' characteristics as early as possible. However, current implant selections for femoral neck fractures remain a topic of greater interest and controversy, and vary substantially from each other depending on the extent of displacement, fracture configuration, physiological age of the patient, bone quality or other relative factors. Nonoperative management is considered only when patients are seriously ill or presented with excessive surgical risk.

Study Type

Interventional

Enrollment (Anticipated)

150

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Hebei
      • Shijiazhuang, Hebei, China, 050000
        • Recruiting
        • The Third Hospital of Hebei Medical University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • closed femoral neck fracture
  • no fractures at other sites
  • surgical treatment with cannulated compression screws or PFNA
  • follow-up time greater than 1 years.

Exclusion Criteria:

  • the absence of severe cognitive dysfunction,
  • the presence of a pathological femoral neck fracture
  • previous femoral neck fracture, treated with other internal fixations and surgical treatment with open reduction.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: three screws fixation
femoral neck fractures were fixed with three converted screws
treated with different fixation method
Experimental: four screws fixation
femoral neck fractures were fixed with four screws
treated with different fixation method

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
outcome measure were evaluated by femoral neck shortening with X rays
Time Frame: up to 12 months
femoral neck shortening after 1 year with radiology measure,
up to 12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
nonunion
Time Frame: up to 12 months
the number of nonunion at the end of follow up in patients
up to 12 months
screw-exit
Time Frame: up to 12 months
screw-exit afer 1 year with X rays in all patients
up to 12 months
cut-out
Time Frame: up t 12 months
cut-out of the screw evaluating with x rays in all patients
up t 12 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
operative time in every patient
Time Frame: intraoperation
outcome measure were evaluated by operative time
intraoperation
fluoroscopy time intraoperatively
Time Frame: intraoperation
outcome measure were evaluated by operative time and fluroscopy time
intraoperation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: zhiyong Hou, MD, Hebei Medical University Third Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2017

Primary Completion (Anticipated)

December 30, 2018

Study Completion (Anticipated)

December 30, 2018

Study Registration Dates

First Submitted

April 23, 2018

First Submitted That Met QC Criteria

May 25, 2018

First Posted (Actual)

June 8, 2018

Study Record Updates

Last Update Posted (Actual)

June 13, 2018

Last Update Submitted That Met QC Criteria

June 11, 2018

Last Verified

June 1, 2018

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

IPD Plan Description

the data should be allowed by Zhang Yingze

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe